3,353
Views
37
CrossRef citations to date
0
Altmetric
Articles

Purification and identification immunomodulatory peptide from rice protein hydrolysates

, , , , , & show all
Pages 150-162 | Received 31 Oct 2018, Accepted 11 Nov 2018, Published online: 01 Mar 2019

Figures & data

Figure 1. Schematic representation of purification and characterization approach used to identify immuno-active peptides from RPHs.

Figure 1. Schematic representation of purification and characterization approach used to identify immuno-active peptides from RPHs.

Figure 2. (A) Elution profile of RPHs on macroporous adsorption resin DA201-C. (B) Murine macrophage proliferation activity (SI) of separated fractions A1-A5. (C) Peptide yield of separated fractions A1–A5. (D) Hydrophobic value (kJ·mol−1) of separated fractions A1-A5.

Figure 2. (A) Elution profile of RPHs on macroporous adsorption resin DA201-C. (B) Murine macrophage proliferation activity (SI) of separated fractions A1-A5. (C) Peptide yield of separated fractions A1–A5. (D) Hydrophobic value (kJ·mol−1) of separated fractions A1-A5.

Figure 3. (A) Elution profile of A3 on strong acid cation resin 001 × 7 column. (B) Murine macrophage proliferation activity (SI) of the separated fractions A3-B1 to A3-B5.

Figure 3. (A) Elution profile of A3 on strong acid cation resin 001 × 7 column. (B) Murine macrophage proliferation activity (SI) of the separated fractions A3-B1 to A3-B5.

Figure 4 (A) Chromatography of fraction A3-B3 on a Sephadex G-10 column. (B) Murine macrophage proliferation activity of each elution fraction. (C) and (D) Fraction A3-B3 molar mass distribution.

Figure 4 (A) Chromatography of fraction A3-B3 on a Sephadex G-10 column. (B) Murine macrophage proliferation activity of each elution fraction. (C) and (D) Fraction A3-B3 molar mass distribution.

Figure 5 (A) Chromatography of the fraction A3-B3-C2 on a C18 column. The inset shows chromatography of fraction A3-B3-C2-D1 on a C18 column. (B) The murine macrophage proliferation activity of control (without fraction A3-B3-C2-D1), IgG (50 µg/mL) and different concentrations of fraction A3-B3-C2-D1.

Figure 5 (A) Chromatography of the fraction A3-B3-C2 on a C18 column. The inset shows chromatography of fraction A3-B3-C2-D1 on a C18 column. (B) The murine macrophage proliferation activity of control (without fraction A3-B3-C2-D1), IgG (50 µg/mL) and different concentrations of fraction A3-B3-C2-D1.

Figure 6. Identification of molecular mass and amino acid sequences of purified peptides (fraction A3-B3-C2-D1-1) by HPLC-ESI-Q-TOF MS system.

Figure 6. Identification of molecular mass and amino acid sequences of purified peptides (fraction A3-B3-C2-D1-1) by HPLC-ESI-Q-TOF MS system.

Table 1. Reported immunomodulating peptides.

Supplemental material

Supplemental Material

Download ()